A Predictive Score for the Ischemic Etiology of a Transient Diplopia (VASCO-DIP)

Launched by FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD · Oct 13, 2015

Keywords

ClinConnect Summary

The VASCO-DIP trial is studying a new scoring system to help doctors identify the cause of transient diplopia, which is a temporary condition where a person sees double for less than 24 hours. This trial is important because some cases of transient diplopia may be due to serious issues that require urgent medical attention, especially those related to blood flow in the brain (known as ischemic causes). The goal is to create a tool that can quickly help healthcare providers recognize when a patient needs emergency care.

To participate in this trial, individuals must be between the ages of 65 and 74 and have experienced transient diplopia within the last 8 days. There are no specific exclusion criteria listed, so many people may be eligible. Participants in the study will undergo assessments based on this new scoring system to see how effectively it identifies the underlying cause of their symptoms. This research could lead to better and faster care for patients experiencing transient diplopia.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Transient diplopia (i.e. less than 24 hours) during the last 8 days
• Exclusion Criteria:
• • -